EVFM
Evofem Biosciences Inc
CEO
Saundra Pelletier
Employees
147
Industry
Pharmaceutical Preparation Manufacturing
Evofem Biosciences, Inc., is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company's first commercial product, Phexxi® (lactic acid, citric acid and potassium bitartrate), is the first and only hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The Company is evaluating EVO100 in a Phase 3 clinical trial, 'EVOGUARD,' for the prevention of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women.
Loading...
Open
0.01
Mkt cap
903K
Volume
84K
High
0.01
P/E Ratio
N/A
52-wk high
0.07
Low
0.01
Div yield
N/A
52-wk low
0.01

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.